Marta Filizola
   HOME

TheInfoList



OR:

Marta Filizola is a computational
biophysicist Biophysics is an interdisciplinary science that applies approaches and methods traditionally used in physics to study biological phenomena. Biophysics covers all scales of biological organization, from molecular to organismic and populations ...
who studies membrane proteins. Filizola's research concerns
drug discovery In the fields of medicine, biotechnology, and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered by identifying the active ingredient from traditional remedies or ...
the application of methods of
computational chemistry Computational chemistry is a branch of chemistry that uses computer simulations to assist in solving chemical problems. It uses methods of theoretical chemistry incorporated into computer programs to calculate the structures and properties of mol ...
and
theoretical chemistry Theoretical chemistry is the branch of chemistry which develops theoretical generalizations that are part of the theoretical arsenal of modern chemistry: for example, the concepts of chemical bonding, chemical reaction, valence, the surface ...
to biochemical and biomedical problems. Filizola is the dean of the graduate school of biomedical sciences at the
Icahn School of Medicine at Mount Sinai The Icahn School of Medicine at Mount Sinai (ISMMS or Mount Sinai), formerly the Mount Sinai School of Medicine, is a private medical school in New York City, New York, United States. The school is the academic teaching arm of the Mount Sina ...
in New York City. Where she is a professor of
pharmacological Pharmacology is the science of drugs and medications, including a substance's origin, composition, pharmacokinetics, pharmacodynamics, therapeutic use, and toxicology. More specifically, it is the study of the interactions that occur between ...
sciences Science is a systematic discipline that builds and organises knowledge in the form of testable hypotheses and predictions about the universe. Modern science is typically divided into twoor threemajor branches: the natural sciences, which stu ...
and
neuroscience Neuroscience is the scientific study of the nervous system (the brain, spinal cord, and peripheral nervous system), its functions, and its disorders. It is a multidisciplinary science that combines physiology, anatomy, molecular biology, ...
, and also the Sharon and Frederick A. Klingenstein-Nathan G. Kase, MD Professor. She is best known for her work aimed at providing mechanistic insight into the
structure A structure is an arrangement and organization of interrelated elements in a material object or system, or the object or system so organized. Material structures include man-made objects such as buildings and machines and natural objects such as ...
, dynamics, and function of
G protein-coupled receptors G protein-coupled receptors (GPCRs), also known as seven-(pass)-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptors, and G protein-linked receptors (GPLR), form a large protein family, group of evoluti ...
using methods such as
molecular modeling Molecular modelling encompasses all methods, theoretical and computational, used to model or mimic the behaviour of molecules. The methods are used in the fields of computational chemistry, drug design, computational biology and materials scienc ...
,
bioinformatics Bioinformatics () is an interdisciplinary field of science that develops methods and Bioinformatics software, software tools for understanding biological data, especially when the data sets are large and complex. Bioinformatics uses biology, ...
,
cheminformatics Cheminformatics (also known as chemoinformatics) refers to the use of physical chemistry theory with computer and information science techniques—so called "'' in silico''" techniques—in application to a range of descriptive and prescriptive ...
, enhanced
molecular dynamics Molecular dynamics (MD) is a computer simulation method for analyzing the Motion (physics), physical movements of atoms and molecules. The atoms and molecules are allowed to interact for a fixed period of time, giving a view of the dynamics ( ...
simulations, and rational
drug design Drug design, often referred to as rational drug design or simply rational design, is the invention, inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic compound, organi ...
approaches. The Filizola laboratory's research has steadily been funded by the
National Institutes of Health The National Institutes of Health (NIH) is the primary agency of the United States government responsible for biomedical and public health research. It was founded in 1887 and is part of the United States Department of Health and Human Service ...
(NIH) since 2005. As of 2016, Filizola is active in five research projects funded by the
National Institute on Drug Abuse The National Institute on Drug Abuse (NIDA) is a United States federal government research institute whose mission is to "advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual ...
(NIDA), the
National Institute of Mental Health The National Institute of Mental Health (NIMH) is one of 27 institutes and centers that make up the National Institutes of Health (NIH). The NIH, in turn, is an agency of the United States Department of Health and Human Services and is the primar ...
(NIMH), and the
National Heart, Lung, and Blood Institute The National Heart, Lung, and Blood Institute (NHLBI) is the third largest Institute of the National Institutes of Health, located in Bethesda, Maryland, United States. It is tasked with allocating about $3.6 billion in FY 2020 in tax revenue t ...
(NHLBI).


Education

A native of Italy, Filizola received her bachelor's and master's degrees in chemistry from th
University Federico II in Naples
(class of 1993), and earned her PhD in computational chemistry from the Second University of Naples in 1999, though conducting most of her doctoral studies at the Department of Chemical Engineering of the Polytechnic University of Catalonia in Barcelona, Spain. She went on to pursue a postdoctorate in computational biophysics from the Molecular Research Institute in California, moving to New York City in 2001.


Career

Filizola joined the Department of Physiology & Biophysics at Mount Sinai School of Medicine (MSSM) as an instructor in 2002. She continued in this role at Weill Medical College (WMC) of
Cornell University Cornell University is a Private university, private Ivy League research university based in Ithaca, New York, United States. The university was co-founded by American philanthropist Ezra Cornell and historian and educator Andrew Dickson W ...
, also in New York City, until she was promoted assistant professor in 2005. She returned to Mount Sinai as an assistant professor in the Department of Structural and Chemical Biology, where she was later promoted associate professor (with tenure since January 2013), and then full professor in 2014. Following three years as co-director of the Structural/Chemical Biology and Molecular Design (SMD) Graduate Program, and one year as co-director of the Biophysics and Systems Pharmacology (BSP) Graduate Program, she was appointed dean of the graduate school of biomedical sciences at Mount Sinai in May 2016. Dr. Filizola has also served as grant reviewer for NIH and other agencies for over 10 years. Currently, she is a regular study section member of the Biophysics of Neural Systems (BPNS) study section of NIH.


Awards and honors

Filizola's awards and honors include the title of European doctor in biotechnology from the European Association for Higher Education in Biotechnology in Genova, Italy (1999), a National Research Service Award from NIDA (2002), The Doctor Harold and Golden Lamport Award for Excellence in Basic Research from Mount Sinai School of Medicine (2008), and an Independent Scientist Award from NIDA (2009–present). She is also a member of the Faculty of 1000 for Pharmacology and Drug Discovery since 2013.


Research

Filizola's research program is mainly focused on G Protein-Coupled Receptors (GPCRs), which are the targets for about half of all currently used drugs. Special effort in her lab has been devoted to the subfamily of opioid receptors to discover/design novel painkillers with reduced abuse liability and other adverse effects. A second important line of investigation in the Filizola lab is on beta3 integrins towards the discovery of novel therapeutics to treat renal, hematologic, neoplastic, bone, and/or fibrotic diseases. To obtain rigorous mechanistic insight into the structure, dynamics, and function of GPCRs and beta3 integrins, the Filizola lab uses several computational structural biology tools, ranging from molecular modeling, bioinformatics, cheminformatics, molecular dynamics simulations, a variety of enhanced sampling algorithms, and rational drug design approaches. Much of the work is done in close collaboration with major experimental labs with whom we have established longstanding synergistic ties. Dr. Filizola is the author of over 100 original papers and chapters in the areas of computational chemistry/biophysics and drug discovery, as well as the editor of 2 books: "G Protein-Coupled Receptors - Modeling and Simulation" and "G Protein-Coupled Receptors in Drug Discovery". She is also an inventor, with a number of patents to her credit.


Publications (partial list)

* * * * * * * * * * * * * * * * * * * *


References


External links


Filizola Laboratory
{{DEFAULTSORT:Filizola, Marta Living people Place of birth missing (living people) Year of birth missing (living people) Women biophysicists Italian women biologists Icahn School of Medicine at Mount Sinai faculty University of Naples Federico II alumni Polytechnic University of Catalonia alumni Italian women academics Computational chemists American women academics 21st-century American women